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Background/aim: Circadian rhythm plays a significant role in the regulation of almost all kinds of physiological processes. In addition,
it may also have a direct or indirect effect on the neurodegenerative processes, including Alzheimer’s disease, Parkinson’s disease, and
ischemic stroke. Therefore, the identification of circadian rhythm-related proteins is crucial to be able to understand the molecular
mechanism of the circadian rhythm and to define new therapeutic target for the treatment of degenerative disorders.
Materials and methods: To identify the light and dark regulated proteins, 8–12 weeks, male Balb/C mice were used at two different
time points (morning (Zeitgeber time-0 (ZT0)) and midnight (ZT18)) under physiological conditions. Therefore, brain tissues were
analyzed via liquid chromatography tandem mass spectrometry.
Results: A total of 1621 different proteins were identified between ZT0 and ZT18 mice. Among these proteins, 23 proteins were
differentially expressed (p < 0.05 and fold change 1.4) in ZT18 mice, 11 upregulated (AKAP10, ALDOC, BLK, NCALD, NFL, PDE10A,
PICAL, PSMB6, RL10, SH3L3, and SYNJ1), and 12 downregulated (AT2A2, AT2B1, CPNE5, KAP3, MAON, NPM, PI51C, PPR1B, SAM50,
TOM70, TY3H, and VAPA) as compared with ZT0 mice.
Conclusion: Taken together, here we identified circadian rhythm-related proteins, and our further analysis revealed that these
proteins play significant roles in molecular function, membrane trafficking, biogenesis, cellular process, metabolic process, and
neurodegenerative disorders such as Parkinson’s disease.
Key words: Circadian rhythm, lc-ms/ms, PDE10A, proteomics, zeitgeber time

1. Introduction
Circadian rhythm does not only regulate our sleep–wake
cycle but also controls almost all kinds of physiological
conditions in our bodies such as body temperature,
hormone secretion, immune regulation, and heart rate
[1,2]. Substantial evidence indicates that almost every
mammalian cell has a circadian clock mechanism.
Although there are a large number of cellular clocks in the
human body, the principal circadian pacemaker in
mammals is located in the suprachiasmatic nucleus (SCN)
of the anterior hypothalamus [3,4]. Many essential
neuronal pathways, including retino-hypothalamic tract
transmit light information from the eyes to the SCN to
synchronize endogenous clockwork to the external
environment.
At the molecular level, circadian locomotor output
cycles protein kaput (CLOCK) and its heterodimer partner
brain and muscle ARNT-like 1 (BMAL1) protein are the
core clock proteins which drive daytime expression of
period (PER) and cryptochrome proteins (CRY). In a
negative transcriptional feedback loop, core clock
proteins BMAL1/CLOCK regulate PER and CRY protein
expression, which allows the circadian cycle to start again.
Moreover, BMAL1 and CLOCK heterodimer complex

regulates the nuclear receptor family of intracellular
transcription factors REV-ERBs and RORs proteins [5].
The circadian rhythm has an essential role in the
regulation of physiological activities as well as in the
pathophysiological processes. In a recent study, it was
demonstrated that most of the ischemic stroke cases occur
in the morning, and they suggested that the occurrence of
stroke showed a circadian distribution [6]. In a previous
study, we demonstrated that time-of-day–dependent
protein expression plays crucial roles in the severity of
brain injury after ischemic stroke in mice [7]. In the same
study, we also showed that midnight ischemiareperfusion injury in mice resulted in significantly
improved neurological behavior, neuronal survival, and
reduced disseminated neuronal injury, brain edema, and
infarct volume compared with ischemia induced in the
morning
[7].
Moreover,
most
prevalent
neurodegenerative diseases including Alzheimer’s
disease, Parkinson’s disease, and Huntington disease, may
cause abnormalities in the circadian rhythm [8].
Due to its important role in almost all physiological
conditions as well as in pathophysiological processes,
circadian rhythm needs to be studied in more detail. In
this context, here we investigated the time-dependent
protein expression from mice striatum via liquid
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chromatography tandem mass spectrometry (LC-MS/MS)
which offers new perspectives in studying biological
processes under physiological conditions, which also
reveal us new therapeutic targets for the development of
neurodegenerative disorders.
2. Materials and methods
2.1. Ethics statement for animal experiments
This study has been conducted in accordance with the
ethical standards according to the Declaration of Helsinki
and according to national and international guidelines and
has been approved by the Ethics Committee of Istanbul
Medipol University (Reference number: 22/01/2020-09).
All animals were maintained under a constant 12-h
light/dark cycle (lights on at 06:00 daily).
2.2. Experimental groups
Experiments were performed using 8–12 weeks Balb/c
male mice. All animals were maintained under a constant
12:12-h light-darkness regimen with ad libitum access to
food and water. A total 14 animals were divided into two
main groups depending on their zeitgeber time (ZT: ZT0
is lights on, and ZT12 is lights off); ZT0 and ZT18. To
evaluate time-dependent protein expression in the
morning (n = 7 mice) and at midnight (n = 7 mice), animals
were sacrificed. In this set, protein profiling was
performed using liquid chromatography tandem mass
spectrometry (LC-MS/MS) analysis.
2.3. Sample preparation for liquid chromatography
tandem mass spectrometry (LC-MS/MS) analysis
Animals were sacrificed at specified times (zeitgeber
times (ZT) 0 or 18). Therefore, the brains were
immediately removed, frozen on dry ice, and stored at –80
C. The brain tissues were taken from striatum and were
homogenized in 50 mM ammonium bicarbonate and lysed
by heating at 95 C in protein extraction reagent kit (UPX
Universal; Expedon). The samples were incubated for 1
hour at 4 C. After the incubation step, the samples were
centrifuged at 14,000 G for 10 min. The supernatants were
then transferred into a microcentrifuge tube. Protein
concentrations of samples were determined via Qubit 3.0
Fluorometer (Q33216, Invitrogen, Life Technologies
Corporation, Carlsbad, CA, USA) according to the
manufacturer’s protocol. As previously reported, FASP
Protein Digestion Kit (ab270519, Abcam, Cambridge, UK)
was used for generating tryptic peptides according to the
manufacturer’s protocol [9]. Briefly, tryptic peptides were
generated according to the filter-aided sample
preparation protocol (FASP). A total of 50 µg protein
samples were filtered using 6M urea in a 30 kDa cut-off
spin column. After this step, the samples were alkylated
with 10 mM iodoacetamide in the dark for 20 min at room
temperature. The samples were then incubated overnight
with MS grade trypsin protease (ratio 1:100, 90057,
Thermo Fisher Scientific, Waltham, MA, USA) at 37 C. The
following day, peptides were eluted from the columns and
1

lyophilized. At the end of the lyophilization process, the
peptides were suspended in 0.1% formic acid
(1002642510, Merck) and diluted to 100 ng/µL before
injecting to the LC-MS/MS system (ACQUITY UPLC MClass coupled to a SYNAPT G2-Si high-definition mass
spectrometer (Waters, Milford, MA, USA)).
2.4. LC-MS/MS analysis and data processing
The liquid chromatography with tandem mass
spectrometry analysis and protein identification were
performed, similar to previously published protocols
[7,10]. The samples were loaded onto the ACQUITY UPLC
M-Class coupled to a SYNAPT G2-Si high-definition mass
spectrometer (Waters). To equilibrate the columns, 97%
of mobile phase (including 0.1% formic acid in UHPLC
grade water) was used and column was heated to 55 C.
Ninety-minute gradient elution from the trap column
ACQUITY UPLC M-Class Symmetry C18 trap column (180
µm × 20 mm; 186007496, Waters) to the analytic column
(ACQUITY UPLC M-Class HSS T3 Column, 100Å, 1.8 µm, 75
µm × 250 mm,; 186007474, Waters) at 0.400 μL/min flow
rate with a gradient from 4% to 40% hypergrade
acetonitrile (100029, Merck) containing 0.1% formic acid
(v/v) was used for the peptide separation. Positive ion
modes of MS and MS/MS scans with 0.7-s cycle time were
performed sequentially. Ten volts was set as low collision
energy and 30 V as high CE. Ion mobility separation (IMS)
was used for the ion separation. A wave velocity was
ramped from 1000 m/s to 55 m/s over the full IMS cycle.
The release time for mobility trapping was set as 500 μs,
trap height was set to 15 V. IMS wave delay was 1000 μs
for the mobility separation after trap release [11]. Without
any precursor ion preselection, all the ions within 50–
1900 m/z range were fragmented in resolution mode.
Additionally, 100 fmol/μL Glu-1-fibrinopeptide B was
infused as lockmass reference with a 60-s interval.
Progenesis-QI for proteomics software (Waters) was used
for the identification and quantification of the peptides.
Whole proteins were identified by at least 2 unique
peptide sequences and then, expression ratio of proteins
was calculated.
Data were further analyzed to understand the role of
these proteins in the biological activities. For this aim,
PANTHER software Protein ANalysis Through
Evolutionary Relationships1 was used and data were
classified according to their role in biological or
physiological activities.
2.6. Western blot
Western blotting was carried out as previously described
[12]. Briefly harvested tissue samples from striatum
belonging to the same group were pooled, homogenized,
and sonicated. The samples were then treated with
protease/phosphatase inhibitor cocktail (5872, Cell
Signaling Technology). Total protein concentration was
determined via Qubit 3.0 Fluorometer (Q33216,
Invitrogen) according to the manufacturer’s protocol.

Geneontology Unifying Biology. Panther Classification System [online]. Web site http://pantherdb.org [accessed 30 March 2021].
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Twenty microgram protein for each sample was loaded to
the 4–20% Mini-PROTEAN TGX Stain-Free protein gels
(4568095, Biorad). Therefore, electrophoresis was
conducted at 150 V at 1.5 h for size-fractionation of the
proteins. At the end of the gel electrophoresis, proteins
were transferred to a polyvinylidene fluoride (PVDF)
membrane using the Trans-Blot Turbo Transfer System
(1704155, Bio-Rad, Hercules, CA, USA). Thereafter, the
membranes were blocked in 5% nonfat dry milk (Blotto;
sc-2324, Santa Cruz Biotechnology, Dallas, TX, USA) in 50
mMol Tris-buffered saline (TBS) containing 0.1% Tween
(TBS-T; blocking solution) for 1 h at room temperature.
After blocking, the step membranes were washed using 50
mMol TBS-T, and incubated overnight with monoclonal
mouse PDE10A (sc-515023; Santa Cruz Biotechnology).
On the next day, the membranes were washed with 50 mM
TBS-T and incubated with horseradish peroxidaseconjugated goat antimouse (405306; Biolegend) antibody
(diluted 1:5000) for 1 h at room temperature. Blots were
performed at least three times. Protein loading was
controlled by stripping and reprobing with polyclonal
rabbit anti-β-actin antibody (622102; Biolegend). Blots
were developed using Amersham ECL Western Blotting
Detection Reagents (RPN2209, GE Healthcare, Chicago, IL,
USA) and visualized using the ChemiDoc MP System
(1708280,
Bio-Rad;
Life
Sciences
Research).
Densitometric analysis was performed to analyze protein
levels via an image analysis software (Image J; National
Institute of Health, Bethesda, MD, USA). Protein levels
were corrected with β-actin blots and expressed as
relative values compared with control (ZT0) group.
2.7. Statistics
For statistical data comparisons, a standard software
package (SPSS 18 for Windows; SPSS Inc., Chicago, IL,
USA) was used. Differences between groups were
analyzed by independent samples t-test. All values are
given as mean ± SD with n values, indicating the number
of samples or animals analyzed. LC-MS/MS data
quantified in Progenesis-QI software was evaluated by
independent samples t-test and 1.4-fold change was
considered significant between ZT0 (morning group) and
ZT18 (midnight group). Throughout the study, p-values <
0.05 were considered significant.
3. Results
For the identification of light- and dark-regulated
proteins, tissue samples at two different zeitgeber time
points (ZT0 and ZT18) were taken from mice striatum
under physiological conditions. Afterward, the samples
were analyzed using the LC-MS/MS method and the
results showed that A-kinase anchor protein 10
(AKAP10), fructose-bisphosphate aldolase C (ALDOC),
sarcoplasmic/endoplasmic reticulum calcium ATPase 2
(AT2A2), plasma membrane calcium-transporting ATPase
1 (AT2B1), tyrosine-protein kinase Blk (BLK), copine-5
(CPNE5), cAMP-dependent protein kinase type II-beta
regulatory subunit (KAP3), NADP-dependent malic
enzyme
(MAON),
neurocalcin-delta
(NCALD),

neurofilament light polypeptide (NFL), nucleophosmin
(NPM), cAMP and cAMP-inhibited cGMP 3',5'-cyclic
phosphodiesterase 10A (PDE10A), isoform 5 of
phosphatidylinositol-binding clathrin assembly protein
(PICAL), phosphatidylinositol 4-phosphate 5-kinase type1 gamma (PI51C), protein phosphatase 1 regulatory
subunit 1B (PPR1B), proteasome subunit beta type-6
(PSMB6), 60S ribosomal protein L10 (RL10), sorting and
assembly machinery component 50 (SAM50), SH3
domain-binding glutamic acid-rich-like protein 3
(SH3L3), synaptojanin-1 (SYNJ1), mitochondrial import
receptor subunit TOM70 (TOM70), tyrosine 3monooxygenase (TY3H), vesicle-associated membrane
protein-associated protein (VAPA) proteins were
significantly altered between ZT0 and ZT18 (Figure 1).
Under physiological conditions AKAP10, ALDOC, BLK,
NCALD, NFL, PDE10A, PICAL, PSMB6, RL10, SH3L3, and
SYNJ1 protein expressions were significantly altered with
respect to dark cycle (Figures 2A–2K). On the other hand,
AT2A2, AT2B1, CPNE5, KAP3, MAON, NPM, PI51C, PPR1B,
SAM50, TOM70, TY3H, and VAPA protein expressions
significantly diminished in the midnight group compared
to the morning group (Figures 3A–3L).
Proteins changing significantly between ZT0 and ZT18
were classified broadly into several categories according
to the Protein ANalysis Through Evolutionary
Relationships (PANTHER)1 classification system. The
proteins were classified based on molecular function as
follows: six binding (ATP2B1, BLK, CPNE5, NPM1,
PICALM, SYNJ1), nine catalytic activity (ALDOC, ATP2A2,
ATP2B1, BLK, MAON, PDE10A, PSMB6, SYNJ1, TY3H), two
structural molecular activity (ATP2A2, ATP2B1), and one
transporter activity (RL10) (Figure 4A). Furthermore,
pathway analysis was performed according to the
proteomic data (Figure 4B). The top scored pathways
were dopamine receptor-mediated signaling (KAP3,
PPR1B, TY3H), Parkinson’s disease (BLK, TY3H), and
nicotine pharmacodynamics (PPR1B, TY3H). In addition,
protein class analysis was performed according to the
proteomic data. These proteins were mapped to three
major protein classes: membrane trafficking protein
(PICALM, VAPA), metabolite interconversion enzyme
(MAON, PIP51C, SYNJ1), and transporter (ATP2A2,
ATP2B1) (Figure 4C). Moreover, these proteins were
mapped to five major biological processes: biogenesis
(BLK, NPM1, PICALM, RL10, SYNJ1, VAPA), biological
regulation (ATP2A2, ATP2B1, BLK, PDE10A, PPR1B),
cellular process (ALDOC, ATP2A2, ATP2B1, BLK, CPNE5,
MAON, NPM1, PDE10A, PICALM, PPR1B, PSMB6, RL10,
SYNJ1, TY3H, VAPA), localization (ATP2A2, BLK, PICALM,
SYNJ1, VAPA), and metabolic process (ALDOC, BLK,
MAON, PSMB6, SYNJ1, TY3H) (Figure 4D).
To validate and confirm proteomics data, PDE10A
protein expression was analyzed from brain tissue via
Western blot (Figure 5A). As in proteomics data, PDE10A
protein level significantly increased in the ZT18 group
compared to the ZT0 group under physiological
conditions.
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Figure 1. List of differentially expressed proteins with respect to ZT0 and ZT18 mice via liquid chromatography mass spectroscopy
(LC-MS/MS). A total of 24 different proteins were significantly regulated (p < 0.05 and >1.4-fold change between ZT0 and ZT18)
depending on the light and dark period.

4. Discussion
The suprachiasmatic nucleus (SCN) of the hypothalamus,
known as the master circadian clock in mammals,
regulates the clock for the body's circadian rhythms [13].
It is well known that circadian rhythm regulates most of
our physiological functions including the sleep–wake
cycle, endocrine system, heart rate, and energy
metabolisms [1,2]. Recent studies suggested that
circadian rhythm plays an important role in the
pathophysiology of neurodegenerative diseases such as
cerebral ischemia, Alzheimer’s disease and Parkinson’s
disease [13–15]. Furthermore, it is speculated that the
clock mechanisms have a direct or indirect effect on both
the triggering of these neurological diseases and the
subsequent damage mechanisms.
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In our previous study, we showed that mice with nighttime focal cerebral ischemia could better tolerate
ischemic injury. In addition, in the same report, we also
analyzed protein expression profiles in different time
points (ZT0, ZT6, ZT12, and ZT18) using proteomic
analyses. We showed that calcium/calmodulin-dependent
serine protein kinase (CSKP), guanine nucleotide-binding
protein z subunit alpha (GNAZ), neuronal growth
regulator 1 (NEGR1), imprinted and ancient protein
(IMPACT), calcium/calmodulin dependent 3′,5′-cyclic
nucleotide phosphodiesterase 1B (PDE1B), and
hemoglobin subunit beta-1, beta-2, and alpha (HBB1,
HBB2, HBA) protein expressions were significantly
altered between morning and midnight in the ischemic
brain tissue [7].
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Figure 2. Significantly increased proteins compared to the ZT0 (morning group) via liquid chromatography mass spectroscopy (LCMS/MS). (A) A-kinase anchor protein 10 (AKAP10), (B) fructose-bisphosphate aldolase C (ALDOC), (C) tyrosine-protein kinase Blk
(BLK), (D) neurocalcin-delta (NCALD), (E) neurofilament light polypeptide (NFL), (F) cAMP and cAMP-inhibited cGMP 3',5'-cyclic
phosphodiesterase 10A (PDE10A), (G) isoform 5 of Phosphatidylinositol-binding clathrin assembly protein (PICAL), (H)
proteasome subunit beta type-6 (PSMB6), (I) 60S ribosomal protein L10 (RL10), (J) SH3 domain-binding glutamic acid-rich-like
protein 3 (SH3L3), and (K) synaptojanin-1 (SYNJ1). All data are expressed as means ± SD values. **p < 0.01/ *p < 0.05 compared

with ZT0 group.
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Figure 3. Significantly decreased proteins compared to the ZT0 (morning group) via liquid chromatography mass spectroscopy
(LC-MS/MS). (A) Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (AT2A2), (B) plasma membrane calcium-transporting
ATPase 1 (AT2B1), (C) copine-5 (CPNE5), (D) cAMP-dependent protein kinase type II-beta regulatory subunit (KAP3), (E) NADPdependent malic enzyme (MAON), (F) nucleophosmin (NPM), (G) phosphatidylinositol 4-phosphate 5-kinase type-1 gamma
(PI51C), (H) protein phosphatase 1 regulatory subunit 1B (PPR1B), (I) sorting and assembly machinery component 50 (SAM50),
(J) mitochondrial import receptor subunit TOM70 (TOM70), (K) tyrosine 3-monooxygenase (TY3H), and (L) vesicle-associated
membrane protein-associated protein A (VAPA). All data are expressed as means ± SD values. **p<0.01/ *p<0.05 compared with
ZT0 group.
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Figure 4. Classification of light- and dark-regulated proteins in mice striatum. Circadian rhythm-related proteins were classified
with respect to (A) molecular function, (B) pathway, (C) protein class, and (D) biological process via Protein ANalysis Through
Evolutionary Relationships (PANTHER1) classification system.
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Figure 5. PDE10A protein expression (A) was analyzed by
Western blot to confirm proteomic analysis. Representative
images of Western blot analysis are given above with their
corresponding graphs. All data are expressed as means ± SD
values (n = 3 blots/ protein). **p<0.01/ *p<0.05 compared
with ZT0 group.

Our main aim in this study was to identify the lightand dark-regulated proteins in the mouse brain via LCMS/MS, which is the most appropriate and popular
technique in proteomic analyses to identify proteins.
Here, we identified 1621 different proteins between the
ZT0 and ZT18 groups. Apart from the core clock proteins
(BMAL1, CLOCK, PER1, and PER2), 23 proteins were
differentially expressed, 12 were downregulated (AT2A2,
AT2B1, CPNE5, KAP3, MAON, NPM, PI51C, PPR1B, SAM50,
TOM70, TY3H, and VAPA), and 11 were upregulated
(AKAP10, ALDOC, BLK, NCALD, NFL, PDE10A, PICAL,
PSMB6, RL10, SH3L3, and SYNJ1), in the ZT18 group as
compared with ZT0 group.
Among these, four proteins (AKAP-10, KAP3, PDE10A,
and PPR1B) are directly or indirectly associated with the
cyclic adenosine monophosphate (c-AMP) signaling
pathway. AKAP-10 binds to the regulatory subunit of the
cAMP-dependent protein kinase also known as protein
kinase A (PKA) which is a serine/threonine protein kinase
[16]. Both KAP3 and PDE10A take part in cyclic-AMP
signaling. PDE10A is highly enriched in medium spiny
neurons (MSNs) of the mammalian striatum and it is
involved in dopamine signaling [17,18]. Recent studies
demonstrated that PDE10A inhibition contributed to
activation of D1- direct and D2-indirect pathway and also
its inhibition by orally activated TAK-063 reduces brain
infarct volume after cerebral ischemia [19,20]. PPR1B also
known as dopamine- and cyclic-AMP-regulated
phosphoprotein of molecular weight 32,000 (DARP-32)
which is a potent inhibitor of protein phosphatase-1 [21].
2712

It was suggested that DARP-32 which is highly abundant
neurons regulates many physiological functions including
ion channel permeability and synaptic plasticity [22].
Although AKAP10 and PDE10A protein expressions are
high at midnight, KAP3 and PPR1B protein levels are high
in the morning hours under physiological conditions.
NCALD, AT2A2 (also known as SERCA2), and AT2B1
play pivotal roles in the calcium homeostasis. NCALD is
primarily involved in neuronal calcium signaling
mechanism and it is speculated that there is a close
relationship between NCAL and adult neurogenesis [23].
SERCA2 is an intracellular calcium pump on the
endoplasmic or sarcoplasmic reticulum, plays an essential
role in regulating calcium homeostasis [24,25]. Like
SERCA2, AB2B1 is also responsible for calcium
transportation. Although NCALD protein expression is
high at the midnight, SERCA2 and AT2B1 protein
expressions are high in the morning.
Results obtained from this study showed that ALDOC,
BLK, NFL, PICAL, PSMB6, RL10, SH3L3, and SYNJ1 protein
expressions are higher at midnight compared to the
morning. It is reported that cardiovascular diseases or
neurological disorders increase ALDOC protein
expression which plays an essential role for the repair of
injured brain tissue [26]. BLK is also known as B lymphoid
tyrosine kinase belonging to the SRC family kinases. It is
responsible for development of B-cell and involved in Bcell receptor signaling [27,28]. In addition, it is predicted
that SRC is a nonreceptor tyrosine kinase that plays an
important role in Parkinson’s disease which is the second
most common neurodegenerative disorders after
Alzheimer’s disease [29]. PSMB6, also known as 20S
proteasome subunit beta-1, codes for the β1 core catalytic
subunit of the proteasome [30]. RL10 is one of large
ribosomal proteins and plays an important role in cell
proliferation, migration, and differentiation [31]. The
function of SH3L3 is largely unknown but it was suggested
that it is upregulated in many cancer types including
pancreatic and lung [32]. Furthermore, NFL, PICAL, and
SYNJ1 proteins play an essential role in Alzheimer’s
disease [33–35]. NFL, also known as neurofilament light
chain, is a biomarker for determining axonal
degeneration. Studies showed that increasing blood NFL
level indicates the severity of the neurodegenerative
diseases including Alzheimer’s disease [33]. SYNJ1 is
highly expressed in nerve terminals and it is important for
vesicle trafficking and coating/uncoating of endocytic
vesicles [35,36]. In addition, it is speculated that SYNJ1
may be an essential target for Alzheimer’s disease.
In addition, CPNE5, MAON, NPM, PI51C, SAM50,
TOM70, TY3H, and VAPA protein expressions were
significantly decreased in the midnight group compared
to the morning group under physiological conditions.
CPNE5 is highly expressed during embryonic
development and it is speculated that it may play a pivotal
role for the development of mouse brain [37]. In a study
using CPNE5 knockout mice, CPNE5 deficiency reduced
the anxiety level in rodents [38]. Mitochondrial MAON,
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encoded by human ME3 gene, is a pivotal member of malic
enzyme family. It plays essential roles in normal insulin
secretion
and
promotes
epithelial-mesenchymal
transition in pancreatic cancer cells [39,40]. B23, also
known as nucleophosmin (NPM), is a neuronal survival
factor which interacts with survival kinase Akt [41]. Type
I phosphotidylinosotol 4-phosphate 5-kinase (PIP5KI) has
three isoforms, α, β, and γ. The PIP5KI γ is highly abundant
in brain and plays an important role in cytoskeletal
organization [42,43]. SAM50 and TOM70 are critical
regulators for mitochondria, and they decrease in the
midnight period under physiological conditions. SAM50 is
a vital component of the sorting and assembly machinery
(SAM) which is an important controller of mitochondrial
dynamics [44]. In addition, TOM70 is the essential subunit
of the translocase of the outer membrane (TOM) which
facilitates the import of mitochondrial proteins from the
cytosol [45]. TY3H is also known as tyrosine hydroxylase
responsible for catalyzing the initial and rate-limiting step
in the biosynthetic pathway of catecholamines (dopamine,
noradrenaline, and adrenaline), thereby directly linking
Parkinson’s disease with tyrosine hydroxylase [46–48].
VAPA participates in cell movement, protein complex
assembly, and vesicular transmission [49].
Classification of identified proteins depending on
molecular function demonstrated that significantly
altered proteins interacted with binding-, catalytic
activity-, structural molecule activity-, and transporter
activity-related proteins. Therefore, three main signal
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transduction pathways were identified as dopamine
receptor-mediated signaling, Parkinson’s disease, and
nicotine pharmacodynamics. In addition, PANTHER
classification based on protein class included 3
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